WO2005124563A3 - Compounds and kits for treating muscle disorders and methods of use thereof - Google Patents
Compounds and kits for treating muscle disorders and methods of use thereof Download PDFInfo
- Publication number
- WO2005124563A3 WO2005124563A3 PCT/US2005/020903 US2005020903W WO2005124563A3 WO 2005124563 A3 WO2005124563 A3 WO 2005124563A3 US 2005020903 W US2005020903 W US 2005020903W WO 2005124563 A3 WO2005124563 A3 WO 2005124563A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- kits
- compounds
- methods
- muscle disorders
- treating muscle
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
- C07C279/12—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/321,782 US20080039531A1 (en) | 2005-06-13 | 2005-12-28 | Compositions, and kits comprising targeted aldehyde or acetal protease inhibitor compounds for treating muscle disorders |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US57891404P | 2004-06-12 | 2004-06-12 | |
US60/578,914 | 2004-06-12 | ||
US63327404P | 2004-12-03 | 2004-12-03 | |
US60/633,274 | 2004-12-03 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/321,782 Continuation-In-Part US20080039531A1 (en) | 2005-06-13 | 2005-12-28 | Compositions, and kits comprising targeted aldehyde or acetal protease inhibitor compounds for treating muscle disorders |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2005124563A2 WO2005124563A2 (en) | 2005-12-29 |
WO2005124563A3 true WO2005124563A3 (en) | 2008-10-02 |
WO2005124563A9 WO2005124563A9 (en) | 2011-09-15 |
Family
ID=35510387
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2005/020903 WO2005124563A2 (en) | 2004-06-12 | 2005-06-13 | Compounds and kits for treating muscle disorders and methods of use thereof |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2005124563A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8729024B2 (en) | 2006-02-28 | 2014-05-20 | The Resesarch Foundation of State University of New York | Targeted delivery of pharmaceutical compounds |
AU2008226823B2 (en) | 2007-03-12 | 2014-03-13 | Nektar Therapeutics | Oligomer-protease inhibitor conjugates |
LT2170396T (en) | 2007-08-03 | 2017-03-10 | Summit (Oxford) Limited | Drug combinations for the treatment of duchenne muscular dystrophy |
GB0715087D0 (en) | 2007-08-03 | 2007-09-12 | Summit Corp Plc | Drug combinations for the treatment of duchenne muscular dystrophy |
US9095620B2 (en) | 2008-03-12 | 2015-08-04 | Nektar Therapeutics | Reagents |
CN104069117A (en) * | 2014-07-03 | 2014-10-01 | 滨州医学院 | Application of amprenavir in preparation of medicine for preventing or treating ischemic cardiovascular and cerebrovascular diseases |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4866040A (en) * | 1986-01-06 | 1989-09-12 | Alfred Stracher | Aminocarnitine directed pharmaceutical agents |
-
2005
- 2005-06-13 WO PCT/US2005/020903 patent/WO2005124563A2/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4866040A (en) * | 1986-01-06 | 1989-09-12 | Alfred Stracher | Aminocarnitine directed pharmaceutical agents |
Also Published As
Publication number | Publication date |
---|---|
WO2005124563A2 (en) | 2005-12-29 |
WO2005124563A9 (en) | 2011-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL233634A0 (en) | Methods, compositions, and kits for the treatment of medical conditions | |
WO2006055871A3 (en) | Treatment for multiple sclerosis | |
WO2006071960A3 (en) | Compositions and methods of treating cell proliferation disorders | |
WO2006023651A3 (en) | Extended treatment of multiple sclerosis | |
WO2005030144A3 (en) | Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders | |
WO2006003388A8 (en) | Compositions and methods for treating inflammatory disorders | |
WO2003082208A8 (en) | Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders | |
ZA200607433B (en) | Methods and compositions for the treatment of gastroin-testinal disorders | |
GB0525041D0 (en) | Methods, assays and compositions for treating retinol-related diseases | |
EP1761266A4 (en) | Compounds, formulations, and methods for treating or preventing inflammatory skin disorders | |
WO2006121421A8 (en) | Methods and formulations for treating glaucoma | |
WO2004084943A8 (en) | Use of antagonists of ghrelin or ghrelin receptor to treat intestinal inflammation | |
WO2006036394A3 (en) | Methods for making retinoids and uses thereof | |
WO2006109301A3 (en) | Molecules and methods of using same for treating mcp-1/ccr2 associated diseases | |
WO2006135694A3 (en) | Uii-modulating compounds and their use | |
WO2005124563A9 (en) | Compounds and kits for treating muscle disorders and methods of use thereof | |
WO2005000208A3 (en) | Combination therapy for the treatment of neoplasms | |
WO2004105696A3 (en) | Combination therapy for the treatment of neoplasms | |
WO2004100873A3 (en) | Compounds, compositions, and methods | |
EP1755637B8 (en) | Methods for preventing or treating bone disorders | |
WO2008085927A3 (en) | Methods, compositions, and kits for the treatment of pain | |
WO2006094134A3 (en) | Kim-1 antibodies for treatment of th2-mediated conditions | |
WO2005077018A3 (en) | Methods of treating skin disorders | |
WO2005110391A3 (en) | Compounds for treating human papillomavirus | |
WO2006012222A3 (en) | Methods of treating smooth muscle cell disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 11321782 Country of ref document: US |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 05760647 Country of ref document: EP Kind code of ref document: A2 |